• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汇集的冷沉淀单位中检测到的血栓的蛋白质组成。

Protein composition of clots detected in pooled cryoprecipitate units.

机构信息

STB LifeSaving Technologies and the American Red Cross, Holland Laboratory, Rockville, Maryland 20855, USA.

出版信息

Transfusion. 2013 Mar;53(3):651-4. doi: 10.1111/j.1537-2995.2012.03778.x. Epub 2012 Jul 15.

DOI:10.1111/j.1537-2995.2012.03778.x
PMID:22804740
Abstract

BACKGROUND

On rare occasions, upon thawing of stored cryoprecipitate components, clots are observed on visual inspection. Although it has been assumed that the clot reflects fibrinogen to fibrin conversion, there are few published studies that document that this assumption is correct. Our studies were conducted to further identify the protein characteristics of the clotted material.

STUDY DESIGN AND METHODS

Clotted material isolated from four thawed cryoprecipitate pools was examined by solubilization procedures and electrophoresis analysis.

RESULTS

Solubilization of much of the clotted material in phosphate-buffered saline warmed to 37°C suggested the presence of soluble fibrin. Gel electrophoresis under reducing conditions showed that the most prevalent bands exhibited molecular weights corresponding to the α, β, and γ subunits of fibrinogen with a much lighter band exhibiting the molecular weight of fibrinogen γ-γ dimer, consistent with the presence of partially crosslinked fibrin. The presence of the dimer indicated that the clotted material was caused by the action of thrombin, but also reflected the action of Factor XIIIa. No ongoing clot formation was observed.

CONCLUSION

Our studies indicate that, on rare occasions, fibrinogen conversion to fibrin is responsible for observable clots in thawed cryoprecipitate pools. These clots are structurally heterogeneous, including both noncrosslinked (soluble) and crosslinked (insoluble) fibrin. This diversity in the fibrin structure may account for some of the diversity in the limited literature regarding their presence in cryoprecipitate pools.

摘要

背景

在极少数情况下,储存的冷沉淀成分解冻后,肉眼观察到有凝块。尽管人们认为凝块反映了纤维蛋白原向纤维蛋白的转化,但很少有发表的研究证明这一假设是正确的。我们的研究旨在进一步确定凝块物质的蛋白质特征。

研究设计和方法

从四个解冻的冷沉淀池分离的凝块物质通过溶解程序和电泳分析进行检查。

结果

在 37°C 温育的磷酸盐缓冲液中溶解大部分凝块物质表明存在可溶性纤维蛋白。在还原条件下的凝胶电泳显示,最常见的带表现出与纤维蛋白原的α、β和γ亚基相对应的分子量,而一个较轻的带表现出纤维蛋白原γ-γ二聚体的分子量,这与部分交联的纤维蛋白的存在一致。二聚体的存在表明凝块物质是由凝血酶引起的,但也反映了因子 XIIIa 的作用。未观察到正在进行的凝块形成。

结论

我们的研究表明,在极少数情况下,纤维蛋白原向纤维蛋白的转化是解冻的冷沉淀池中可观察到凝块的原因。这些凝块在结构上是异质的,包括未交联(可溶性)和交联(不溶性)纤维蛋白。纤维蛋白结构的这种多样性可能解释了关于其在冷沉淀池中的存在的有限文献中的一些多样性。

相似文献

1
Protein composition of clots detected in pooled cryoprecipitate units.汇集的冷沉淀单位中检测到的血栓的蛋白质组成。
Transfusion. 2013 Mar;53(3):651-4. doi: 10.1111/j.1537-2995.2012.03778.x. Epub 2012 Jul 15.
2
Preparation and characterization of human thrombin for use in a fibrin glue.用于纤维蛋白胶的人凝血酶的制备与表征
Transfus Med. 2007 Jun;17(3):187-91. doi: 10.1111/j.1365-3148.2006.00717.x.
3
Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.解冻后混合的冷沉淀在冷藏温度下保存 24 小时的特性。
Blood Transfus. 2018 Sep;16(5):443-446. doi: 10.2450/2017.0133-17. Epub 2017 Oct 30.
4
Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.纤维蛋白原巴尔的摩向纤维蛋白转化过程中α-聚合缺陷。
J Clin Invest. 1975 Jun;55(6):1190-4. doi: 10.1172/JCI108036.
5
Soluble crosslinked fibrin(ogen) polymers.可溶性交联纤维蛋白(原)聚合物
Thromb Haemost. 1985 Dec 17;54(4):804-7.
6
Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20-24°C for up to 24 h.在20 - 24°C储存长达24小时期间,单单位或冷沉淀池内凝血蛋白活性的稳定性。
Vox Sang. 2016 Jan;110(1):12-9. doi: 10.1111/vox.12309. Epub 2015 Jul 14.
7
The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.解冻后混合冷沉淀在长达72小时内的止血特性。
Transfusion. 2016 Jun;56(6):1356-61. doi: 10.1111/trf.13571. Epub 2016 Mar 28.
8
Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.亚甲蓝处理的血浆和冷沉淀中的凝血酶生成及凝块形成。
Transfusion. 2009 Apr;49(4):696-703. doi: 10.1111/j.1537-2995.2008.02039.x. Epub 2009 Jan 5.
9
Extending the post-thaw viability of cryoprecipitate.延长冷冻沉淀解冻后的存活时间。
Transfusion. 2021 May;61(5):1578-1585. doi: 10.1111/trf.16366. Epub 2021 Mar 17.
10
Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.纤维蛋白肽A和B差异释放后纤维蛋白原的可凝性和交联反应性
Thromb Haemost. 1976 Dec 31;36(3):582-92.

引用本文的文献

1
Use of Cryoprecipitate in Newborn Infants.冷沉淀在新生儿中的应用。
Newborn (Clarksville). 2023 Jan-Mar;2(1):11-18. doi: 10.5005/jp-journals-11002-0045. Epub 2023 Apr 6.
2
The effects of intraoperative cryoprecipitate transfusion on acute renal failure following orthotropic liver transplantation.术中输注冷沉淀对原位肝移植术后急性肾衰竭的影响。
Hepatol Int. 2013 Jul;7(3):901-9. doi: 10.1007/s12072-013-9457-9. Epub 2013 Aug 2.
3
Cryoprecipitate therapy.冷沉淀疗法。
Br J Anaesth. 2014 Dec;113(6):922-34. doi: 10.1093/bja/aeu158. Epub 2014 Jun 27.